Facial basal cell carcinomas treated with hypo-fractionated radiotherapy: A retrospective analysis in 117 elderly patients

被引:12
|
作者
Pelissero, Antonio [1 ]
Russi, Elvio G. [1 ]
Melano, Antonella [1 ]
Fillini, Claudia [1 ]
Vigna-Taglianti, Riccardo [1 ]
Settineri, Nicola [2 ]
Lucio, Francesco [1 ]
Girolomoni, Giampiero [4 ]
Pergolizzi, Stefano [3 ]
机构
[1] AOS Croce & Carle Cuneo, Dept Radiat Oncol, I-12100 Cuneo, Italy
[2] Univ Messina, Dept Radiol Sci, I-98100 Messina, Italy
[3] Univ Messina, Radiat Oncol Dept Unit, I-98100 Messina, Italy
[4] Univ Verona, Dept Med, Sect Dermatol & Venereol, I-37100 Verona, Italy
关键词
NECK; HEAD;
D O I
10.1016/j.jaad.2015.03.030
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:166 / 168
页数:4
相关论文
共 50 条
  • [31] Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis
    Thien Nguyen
    Duong, Courtney
    Sheppard, John P.
    Lee, Seung Jin
    Kishan, Amar U.
    Lee, Percy
    Tenn, Stephen
    Chin, Robert
    Kaprealian, Tania B.
    Yang, Isaac
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 166 : 116 - 123
  • [32] Individualized Hypo-fractionated Radiotherapy (IHRT) for Advanced Hepatocellular Carcinoma (HCC): 11-Year Experience of 172 patients
    Wong, N. S. M.
    Chiang, C. L.
    Chiu, W. H. K.
    Ho, C. H.
    Zhang, S.
    Ha, J. S.
    Yeung, C. S. Y.
    Chan, M.
    Lee, V. W.
    Lee, A. S.
    Wong, C. S. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S159 - S159
  • [33] Retrospective analysis of the histopathologic features of basal cell carcinomas in pediatric patients with basal cell nevus syndrome
    Nguyen, Cuong V.
    Rubin, Adam I.
    Smith, Anna
    Castelo-Soccio, Leslie
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (03) : 390 - 395
  • [34] Facial Basal Cell Carcinomas Recurring after Photodynamic Therapy: A Retrospective Analysis of Histological Subtypes
    Fiechter, Sabine
    Skaria, Andre
    Nievergelt, Helga
    Anex, Romain
    Borradori, Luca
    Parmentier, Laurent
    DERMATOLOGY, 2012, 224 (04) : 346 - 351
  • [35] Dermatologic radiotherapy in the treatment of extensive basal cell carcinomas: a retrospective study
    Piccinno, R.
    Benardon, S.
    Gaiani, F. M.
    Rozza, M.
    Caccialanza, M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (05) : 426 - 430
  • [36] Hypo-Fractionated Accelerated Radiotherapy in Central Early Non-Small Cell Lung Cancer: Leeds Cancer Centre Experience
    Janjua, T.
    Arunsingh, M.
    Clarke, K.
    Dickinson, P.
    Franks, K.
    Murray, P.
    Snee, M.
    Teo, M.
    Jain, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S837 - S838
  • [37] Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
    Roger, Anissa
    Finet, Adeline
    Boru, Blandine
    Beauchet, Alain
    Mazeron, Jean-Jacques
    Otzmeguine, Yves
    Blom, Astrid
    Longvert, Christine
    de Maleissye, Marie-Florence
    Fort, Magali
    Funck-Brentano, Elisa
    Saiag, Philippe
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [38] Basal cell carcinomas in radiotherapy-treated port wine stains
    Sattler, E.
    Raewer, H. -C.
    Muehlstaedt, M.
    Ruzicka, T.
    Burgdorf, W.
    Kunte, C.
    HAUTARZT, 2011, 62 (07): : 534 - 538
  • [39] Predictors of failure for PS2-3 patients undergoing hypo-fractionated radical radiotherapy for NSCLC - experience of a UK centre
    Horsley, A.
    Hsu, J. K.
    McPartlin, A.
    Bayman, N.
    Faivre-Finn, C.
    Chittalia, A. Z.
    Burt, P. A.
    Coote, J. H.
    Lee, L. W.
    Sheikh, H. Y.
    Harris, M. A.
    Pemberton, L.
    LUNG CANCER, 2015, 87 : S56 - S56
  • [40] Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases
    Liang, Xuexia
    Jiang, Yanhui
    Yao, Wei
    Deng, Yun
    Yang, Shuai
    Liu, Qiaodan
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (03) : 1508 - 1518